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Applying NPWT to bleeding open wounds after
forefoot amputation in diabetic foot patients –
a case report
Jacek Białecki, Przemysław Pyda, Anna Kołodziejska, Anna Rybak, Sebastian Sowier
CASE REPORT
Abstract— NPWT is increasingly used in patients with
diabetic foot. The protocol for performing NPWT is subject
to debate. Main concerns regard the type of suction to use
(continuous, intermittent, or variable), the wound-packing ma-
terial, or the exact pressure to apply. Typically, an optimum
pressure range of –80 to –125 mmHg is indicated. Following
bone resection in diabetic foot patients, the surgical wound is
left open, which often entails bleeding from the resection site. In
these cases, the start of NPWT was typically delayed by 24–48
hours – during that time a pressure dressing was applied – and
NPWT was only started once bleeding had ceased. In order to
initiate NPWT as soon as possible, we decided to start it at a
higher negative pressure than usual, i.e. –180 mmHg, expecting
that this would stop the bleeding. Only then would we reduce the
negative pressure. This paper presents the course of NPWT with
high negative pressure values after an amputation in 2 diabetic
foot patients. In both cases, our assumptions were confirmed.
The patients did not bleed, the drained volume did not exceed 30
ml (which seems clinically insignificant) in the first 40 minutes
of treatment. Later, with negative pressure at –120 mmHg, no
bleeding into the dressing was observed. Following the treatment
(which lasted for 9 days), the wounds granulated normally, with
no signs of inflammation. Applying VAC dressing using high
negative pressure values to bleeding wounds immediately after
surgery may stop the bleeding, enabling immediate initiation of
NPWT.
Keywords—negative pressure wound therapy, diabetic foot,
amputation, bleeding
I. INTRODUCTION
NEGATIVE pressure wound therapy (NPWT) is increas-ingly used in patients with diabetic foot, both in treat-
ing wounds caused by ulceration, and in healing surgical
wounds following bone resection. NPWT assists in wound
healing in a number of ways: it drains exudate, contracts
the wound edges, alters blood flow in the wound edges,
stimulates angiogenesis, reduces tissue edema, stimulates the
formation of granulation tissue, creates a moist environment,
and stimulates the wound bed.1–3 Multiple studies indicate
that NPWT is superior to other wound dressing methods
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in the treatment of diabetic foot.4–6 The protocol for per-
forming NPWT is subject to debate. Indications for when
NPWT should and should not be used have been established
quite clearly.7, 8 However, indications regarding the type of
suction to use (continuous, intermittent, or variable),1, 9–11
the wound-packing material,1, 12, 13 or the exact pressure to
apply14–17 are less definitive. Typically, an optimum pressure
range of –80 to –125 mmHg is indicated, though other
recommendations can also be found: Timmers et al. (2005)
suggest, for instance, that the best wound healing outcomes
can be achieved at pressures ranging from –250 to –300
mmHg.18 Following bone resection in diabetic foot patients,
the surgical wound is left open, which often entails bleeding
from the resection site. In these cases, the start of NPWT
was typically delayed by 24–48 hours – during that time a
pressure dressing was applied – and NPWT was only started
once bleeding had ceased. This was due to the widespread
belief that applying NPWT immediately after the surgery
might increase bleeding. However, in order to initiate NPWT
as soon as possible, we decided to start it at a higher negative
pressure than usual, i.e. –180 mmHg, expecting that this
would stop the bleeding. Only after achieving hemostasis
would we reduce the negative pressure. This paper presents
the course of NPWT with high negative pressure values after
an amputation in 2 diabetic foot patients.
II. CASE REPORT
A. Surgical interventions
Patient A (53 years old), suffering from type-2 diabetes,
hypertension, and coronary artery disease, was referred to
our hospital with necrosis of the fourth toe and extensive
phlegmon of the right foot. Initial debridement of the wound
was performed on an outpatient basis: an amputation of the
fourth toe was performed and the drainage of the subcuta-
neous forefoot tissue was initiated (Fig. 1). Subsequently, the
patient was admitted to our hospital for further diagnostics
and therapy. A blood culture test was run and a targeted an-
tibiotic therapy was initiated (Ciprofloxacin 2 x 400 mg i.v.).
After 4 days of conservative treatment, clinical symptoms of
ischemia in the distal parts of the limb were found. Therefore
a computed tomography angiography of lower limbs was
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Figure 1. A wound after an amputation of the fourth toe. On the back of
the foot, there are small incisions from drains placed in the outpatient clinic.
performed. A critical constriction of the superficial femoral-
artery of the left limb was discovered. A vascular recon-
structive surgery was performed – reversed femoral-popliteal
saphenous vein bypass. A proper blood supply was obtained,
which was confirmed by a Doppler ultrasonography. In
the first week post-operatively, an inflammatory progression
occurred in the distal part of the limb. Extensive necrosis
developed in the fifth toe and part of the subcutaneous
tissue of the forefoot and sole. The patient underwent non-
anatomical amputation of the fifth toe, and resection of the
fourth and fifth metatarsophalangeal joints together with the
distal parts of the fourth and fifth metatarsal bones (Fig. 2).
A broad-spectrum antibiotic therapy was initiated (Tazocin 3
x 4.5g i.v.). Throughout the entire hospital stay the patient
continued insulin therapy (Insulatard: 16 u – 0 u – 28 u;
NovoRapid: 16 u – 10 u – 8 u) and Clexane was administered
subcutaneously (1 x 40 mg).
Patient B (55 years old), suffering from Charcot foot and
diabetic foot ulcer, previously managed on an outpatient ba-
sis, was admitted to our hospital with extensive phlegmon in
the left crus and foot. Crural amputation was performed, with
standard suturing of the stump. Despite targeted antibiotic
treatment (Imipenem 500 mg/Cilastatin 500 mg x 4 i.v.),
3 days post-operatively massive phlegmon developed in the
stump tissues, with inflammatory infiltration of the soft tissue
of the thigh. Surgical wound revision was performed, which
Figure 2. A bleeding wound after a non-anatomical amputation of the fifth
toe, and resection of the fourth and fifth metatarsophalangeal joints together
with the distal parts of the fourth and fifth metatarsal bones.
Figure 3. Revision of the crural stump following the amputation.
involved removing sutures from the skin and muscle, and
dissecting the skin and subcutaneous tissue from the lateral
part of the thigh along the inflammatory infiltrate. Pus was
evacuated, and infected and necrotic tissue was removed (Fig.
3). Throughout the entire hospital stay the patient continued
insulin therapy (Humulin N: 16 u – 0 u – 14 u; Humalog 14 u
– 12 u – 10 u) and Clexane was administered subcutaneously
(1 x 100 mg).
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Figure 4. Foot after fourth and fifth metatarsal bone amputation, with the
VAC dressing applied immediately after the procedure.
B. NPWT treatment
In both cases, despite parenchymatous bleeding from
the surrounding tissue, a VAC dressing (Renasys-F, On-
tario, Canada) was applied immediately after the surgery. A
polyurethane foam dressing was cut to fit the wound (Fig. 4).
The dressing was sealed and NPWT was started. A pressure
of –180 mmHg was applied for the first 30 minutes after
the procedure, then –140 mmHg for the next 10 minutes.
Subsequently, the negative pressure was reduced to –120
mmHg and maintained until the end of treatment.
In both cases, our assumptions were confirmed. The pa-
tients did not bleed, the drained volume did not exceed 30 ml
(which seems clinically insignificant) in the first 40 minutes
of treatment. Treatment continued for 3 days, after which
the dressing was changed. Then, NPWT was continued for
the next two 3-day cycles, with the dressing changed again
on the 6th post-operative day. Throughout the entire 9-day
treatment the wound did not bleed. The VAC dressing drained
a mean volume of 40 ml of serosanguineous exudate per day.
Following the treatment, the wounds granulated normally,
with no signs of inflammation (Fig. 5).
III. DISCUSSION
NPWT is now commonly used in the treatment of diabetic
foot. Though general indications for the treatment have been
Figure 5. Wound site with VAC dressing removed after 9 days of NPWT.
established, no single protocol has been developed. Reports
from a number of centers indicate that in cases of open
wounds following amputation or bone resection in patients
with diabetic foot, early start of NPWT may trigger or exac-
erbate bleeding. Hence, treatment start was typically delayed
by 24–48 hours, until after hemostasis had been achieved.
This is also the protocol recommended by some authors.19, 20
The standard method for the achievement of hemostasis
is electrocoagulation. However, in cases of diabetic foot,
this creates multiple new thermal necrosis sites, which is
undesirable, particularly if infection exists. Another method
for managing bleeding from the surgical wound involves
applying a pressure dressing, which restricts blood flow to
the tissues. However, this delays the start of NPWT, while the
larger volume of secretions remaining in the wound increases
treatment time. If the tissues surrounding the wound are
infected, it is desirable to apply NPWT as soon as possible,
which allows for early drainage of the secretions that inhibit
wound healing due to the content of proinflammatory factors.
To effectively remove the secretions from the wound, we
decided to apply a VAC dressing onto the fresh wound,
immediately after the surgery. Bearing in mind the concerns
related to bleeding, we attempted to adjust the negative
pressure in a way ensuring the evacuation of secretions
without causing bleeding. Some studies on NPWT discuss
the impact of the negative pressure in the dressing on blood
supply to the surrounding tissue. (It should be noted that
measurements to determine the optimum negative pressure
value are performed on tissues with a specific compactness
— therefore, their results should not be automatically used
to prescribe pressure values for use in tissues with different
properties. For instance, different pressures may be optimal
for the abdominal wall and for the foot.) Wackenfors et
al., studying the impact of negative pressure values ranging
between –50 and –200 mmHg on microvascular blood flow
around the wound in porcine models, reported that the use of
NPWT may reduce microvascular blood flow in the tissues
directly adjacent to the wound, and that the higher the
negative pressure value, the greater the affected area.21, 22
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Based on this report and our own experience with NPWT, we
decided to apply a negative pressure of –180 mmHg for the
first 30 minutes, to prevent bleeding. The negative pressure
was then reduced to –140 mmHg for the next 10 minutes.
After that, treatment was continued at the standard pressure
of –120 mmHg. This allowed us to start NPWT immediately
after the surgery without increasing the risk of bleeding.
Further observations are required to develop a protocol for
NPWT after amputations in diabetic foot patients.
IV. CONCLUSION
Applying VAC dressing using high negative pressure val-
ues to bleeding wounds immediately after surgery may stop
the bleeding, enabling immediate initiation of NPWT. Further
observations are required to develop a protocol for NPWT
after amputations in diabetic foot patients.
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